Navigating Rare Disease Submissions: Minoryx Stresses Early EMA Engagement

 
• By Manas Mishra
  
Minoryx charts a course towards European approval for leriglitazone despite initial setbacks (Shutterstock)

More from EU CHMP

More from Approval Standards